ConcertAI
PrivateLast Round
Series C
Mar 29, 2022
Est. Valuation
$1.9B
Total Funding Raised
$300M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ConcertAI operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series C round in March 2022.
ConcertAI is a healthcare technology company that provides enterprise AI and real-world data (RWD) solutions to accelerate clinical research, improve clinical trial efficiency, and enhance patient outcomes in oncology and other complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Clinical Trials, Medical AI, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ConcertAI Comparables
Compare ConcertAI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Roche Holding | 81% | |
| Verana Health | 81% | |
| Paradigm Health | 80% |
For institutional investors. Book with your work email.
ConcertAI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 29, 2022 | ||||
| Series B | Jan 13, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ConcertAI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maverick Ventures | Series B |
| Sixth Street Partners | Series C |
| Declaration Partners | Series B |
| Sixth Street Growth | Series C |
| AB Private Credit Investors | Series B |
| SymphonyAI Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 69% MoM, reaching 57.9K.
- Apr 10, 2026
CancerLinQ is now part of ConcertAI.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asSep 17, 2026
TIME names ConcertAI to its World's Top HealthTech Companies of 2026 in the AI & Data Analytics category for advancing healthcare through real-world data and applied AI.
For institutional investors. Book with your work email.
ConcertAI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ConcertAI's valuation, stock price, and market status.
Is ConcertAI a public or private company?
ConcertAI is a private company.
What is the current stock price of ConcertAI?
ConcertAI is a private company, so its shares have no public market price. Caplight tracks ConcertAI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ConcertAI worth (valuation)?
ConcertAI's valuation is estimated at $1.9B based on funding round data.
Can I buy ConcertAI stock?
ConcertAI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ConcertAI's last funding round?
ConcertAI's most recent funding round was Series C on March 29, 2022.
Who are the main investors in ConcertAI?
Key investors in ConcertAI include Sixth Street Partners, Declaration Partners, Sixth Street Growth.
Will ConcertAI IPO soon?
No public IPO plans have been announced for ConcertAI.
How can I track ConcertAI secondary market activity?
Caplight tracks bids, offers, and trades in ConcertAI's shares on secondary markets.